Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 407,838
  • Shares Outstanding, K 256,502
  • Annual Sales, $ 0 K
  • Annual Income, $ -81,350 K
  • 60-Month Beta 3.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.51
Trade OCGN with:

Options Overview Details

View History
  • Implied Volatility 164.00% ( +4.92%)
  • Historical Volatility 127.72%
  • IV Percentile 29%
  • IV Rank 14.70%
  • IV High 1,030.35% on 11/09/23
  • IV Low 14.65% on 08/14/23
  • Put/Call Vol Ratio 0.21
  • Today's Volume 1,424
  • Volume Avg (30-Day) 5,832
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 87,954
  • Open Int (30-Day) 70,135

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0100 +57.43%
on 03/18/24
2.1050 -24.47%
on 03/25/24
+0.5100 (+47.22%)
since 03/15/24
3-Month
0.4905 +224.16%
on 01/19/24
2.1050 -24.47%
on 03/25/24
+1.0299 (+183.88%)
since 01/16/24
52-Week
0.3450 +360.87%
on 10/26/23
2.1050 -24.47%
on 03/25/24
+0.7898 (+98.70%)
since 04/14/23

Most Recent Stories

More News
3 Standout Penny Stocks to Watch This April

Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according...

OCGN : 1.5900 (unch)
VERU : 1.2550 (-17.97%)
DM : 0.8510 (-0.92%)
$SPX : 5,051.41 (-0.21%)
Ocugen (OCGN) Q4 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2024.

OCGN : 1.5900 (unch)
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street

Could these biotech companies still win in the vaccine market and beyond?

NVAX : 3.99 (-3.16%)
OCGN : 1.5900 (unch)
Ocugen (OCGN) Q3 2023 Earnings Call Transcript

OCGN earnings call for the period ending September 30, 2023.

OCGN : 1.5900 (unch)
Ocugen (OCGN) Q2 2023 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2023.

OCGN : 1.5900 (unch)
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?

These companies haven't given up on the coronavirus vaccine market.

MRNA : 103.79 (-0.07%)
PFE : 25.69 (-0.85%)
NVAX : 3.99 (-3.16%)
OCGN : 1.5900 (unch)
Ocugen (OCGN) Q1 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2023.

OCGN : 1.5900 (unch)
Why Ocugen Stock Eked Out a Win Today

The company is clearly progressing on several fronts with its pipeline programs.

OCGN : 1.5900 (unch)
Ocugen (OCGN) Q4 2022 Earnings Call Transcript

OCGN earnings call for the period ending December 31, 2022.

OCGN : 1.5900 (unch)
More Likely to 5x First: Novavax vs. Ocugen

They skyrocketed before. It could happen again.

NVAX : 3.99 (-3.16%)
OCGN : 1.5900 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 1.7000
2nd Resistance Point 1.6500
1st Resistance Point 1.6200
Last Price 1.5900
1st Support Level 1.5400
2nd Support Level 1.4900
3rd Support Level 1.4600

See More

52-Week High 2.1050
Last Price 1.5900
Fibonacci 61.8% 1.4327
Fibonacci 50% 1.2250
Fibonacci 38.2% 1.0173
52-Week Low 0.3450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar